MT-1 peptide, also called Melanotan-1, is a synthetic tanning peptide sold online and the base of an FDA-approved drug for a rare disease. Learn more.
MT-1 peptide is a synthetic, lab-made copy of alpha-melanocyte-stimulating hormone (α-MSH), the body's own signal for making melanin. In the United States, the only legal form of it is afamelanotide (brand name Scenesse), a prescription implant approved for a rare sun-sensitivity disorder — not for cosmetic tanning. Unapproved "melanotan-1" vials, preloaded syringes, and nasal sprays sold online carry the same peptide name but none of the regulatory oversight.
What Is the MT-1 Peptide?
MT-1 is short for melanotan-1, a man-made peptide first designed in the 1980s. It is a linear chain of 13 amino acids built to mimic α-MSH, the natural hormone that tells pigment cells to ramp up melanin production.
Afamelanotide is the pharmaceutical-grade version of MT-1. It is far more potent than natural α-MSH and breaks down more slowly, which is why it can be delivered as a slow-release implant placed under the skin every two months rather than injected daily.
In the US, afamelanotide is approved only for erythropoietic protoporphyria (EPP), a rare genetic condition that causes severe, painful burning reactions to sunlight within minutes of exposure. Afamelanotide is not FDA-approved as a tanning agent, and the FDA has separately warned consumers away from unapproved melanotan products.
How MT-1 Peptide Works
MT-1 binds to melanocortin-1 receptors (MC1R) on melanocytes, the pigment-producing cells in the skin. That binding triggers a cascade that increases eumelanin, the darker, more UV-absorbing form of melanin.
Because the effect runs through the body's own pigment machinery, MT-1 does not create a tan overnight. In clinical studies of EPP patients, melanin density rose gradually over days to weeks, and photoprotection built along with it.
One important point: a drug-induced tan is not a substitute for sunscreen. Pigment adds some protection, but it does not block UV damage, and the underlying stimulus — UV exposure — still raises skin cancer risk.
MT-1 vs. MT-2 vs. Afamelanotide
People often use "melanotan" as if it were one thing. It is not. MT-1, MT-2, and afamelanotide differ in structure, potency, and legal status.
| Compound | Structure | FDA status | Commonly reported effects |
|---|---|---|---|
| MT-1 (melanotan-1) | Linear 13-amino-acid peptide | Not approved as a tanning product | Gradual skin darkening, nausea, flushing, mole darkening |
| MT-2 (melanotan II) | Cyclic peptide | Not approved for any use | Tanning plus nausea, flushing, spontaneous erections |
| Afamelanotide (Scenesse) | Same peptide as MT-1, pharmaceutical grade | Approved for EPP only, prescription | Headache, nausea, implant-site reactions |
Afamelanotide's approval grew out of decades of peptide drug development, in which researchers engineer short amino acid chains to hit specific receptors with fewer off-target effects. The same chemistry now supports work on peptide drug conjugates, which pair a targeting peptide with a drug payload to deliver treatment to specific cells.
Those are controlled research programs with defined doses and monitoring. A gray-market vial purchased online has none of that.
Is MT-1 Peptide Legal in the United States?
Prescription afamelanotide is legal and is dispensed through specialty clinics for patients who meet the EPP criteria. That is the only lawful route to MT-1 in the US.
Everything else marketed as melanotan-1 — injectable powders, nasal sprays, tanning "stacks" — is unapproved. The FDA has stated that these products are unapproved new drugs and has warned that they are often mislabeled, contaminated, or dosed incorrectly.
The gap between regulated and gray-market peptides shows up across the field. A bpc-157 peptide for inflammation is widely sold online even though it has no approved human indication, and buyers face the same purity and dosing unknowns.
MT-1 Side Effects and Safety Concerns
Reported effects from unapproved melanotan products include:
- Nausea and vomiting, sometimes within minutes of injection
- Facial flushing and warmth
- Fatigue and headache
- Darkening of existing moles, freckles, and lips
- Injection-site pain, bruising, or infection from nonsterile product
- Rare but serious: priapism, reported mainly with MT-2
Mole darkening is more than cosmetic. It makes it harder for a dermatologist to spot early melanoma, and researchers have flagged MC1R stimulation as a theoretical cancer concern that has not been ruled out.
In clinical trials of afamelanotide, the most frequent side effects were headache, nausea, and implant-site reactions. Patients on the implant are monitored over the long term because the drug's safety profile beyond a few years of use is still being characterized.
Safer Alternatives and What to Do Instead
If sun protection is the goal, the evidence-backed tools are still broad-spectrum sunscreen, protective clothing, shade, and vitamin D from food or supplements. For people with EPP, an FDA-approved prescription exists and should be discussed with a specialist.
If the goal is skin appearance rather than a tan, topicals have a far better safety record. People searching for the best peptide cream dermatologist recommendations are usually chasing firmer, smoother-looking skin, and a board-certified dermatologist can point to ingredients with real trial data behind them.
Oral products sold as natural peptide supplements are not a substitute for an injectable melanocortin agonist, and there is no credible evidence that they produce tanning. "Natural" also is not a safety guarantee — supplement manufacturing is held to looser standards than prescription drugs.
Anyone considering a melanocortin peptide for any reason should talk with a healthcare professional first, especially people with a personal or family history of melanoma, atypical moles, or cardiovascular conditions. No peptide currently on the market is a proven cure for anything beyond its approved indication.
Frequently Asked Questions
Is MT-1 peptide the same thing as Melanotan-1?
Yes. MT-1 is shorthand for melanotan-1, a synthetic 13-amino-acid analog of alpha-MSH. Afamelanotide is the pharmaceutical form of that same peptide, used in the FDA-approved implant Scenesse. MT-2 (melanotan II) is a different, cyclic peptide with a distinct risk profile.
Is MT-1 peptide legal in the United States?
Afamelanotide, the prescription form of MT-1, is legal in the US but only for erythropoietic protoporphyria. Nonprescription melanotan-1 sold online is not FDA-approved, and the agency has warned that such products are unapproved and often mislabeled. Buying them means injecting a substance of unknown purity and dose.
How long does MT-1 peptide take to work?
In clinical studies of afamelanotide in EPP patients, melanin density increased gradually over days to weeks rather than in hours. There is no evidence it produces a rapid tan, and it is not a replacement for sunscreen. Results vary with skin type and MC1R genetics.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.